Cargando…

Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity

Asymptomatic individuals, called “silent spreaders” spread SARS-CoV-2 efficiently and have complicated control of the ongoing COVID-19 pandemic. As seen in previous influenza pandemics, socioeconomic and life-trajectory factors are important in disease progression and outcome. The demographics of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holuka, Cyrielle, Snoeck, Chantal J., Mériaux, Sophie B., Ollert, Markus, Krüger, Rejko, Turner, Jonathan D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157140/ https://www.ncbi.nlm.nih.gov/pubmed/34067606 http://dx.doi.org/10.3390/jcm10102159

Ejemplares similares

IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection
por: Quinti, Isabella, et al.
Publicado: (2021)

Association of plasma zinc levels with anti-SARS-CoV-2 IgG and IgA seropositivity in the general population: A case–control study
por: Equey, Antoine, et al.
Publicado: (2023)

The COVID-19 Pandemic: Does Our Early Life Environment, Life Trajectory and Socioeconomic Status Determine Disease Susceptibility and Severity?
por: Holuka, Cyrielle, et al.
Publicado: (2020)

Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples
por: Meyrath, Max, et al.
Publicado: (2022)

Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2
por: Klingler, Jéromine, et al.
Publicado: (2020)

Salivary IgAs and Their Role in Mucosal Neutralization of SARS-CoV-2 Variants of Concern
por: Diem, Gabriel, et al.
Publicado: (2022)

Enhanced SARS-CoV-2 neutralization by dimeric IgA
por: Wang, Zijun, et al.
Publicado: (2021)

IgA Nephropathy After SARS-CoV-2 Vaccination
por: Abramson, Matthew, et al.
Publicado: (2021)

Prevalence of antigliadin IgA antibodies in psoriasis vulgaris and response of seropositive patients to a gluten-free diet
por: Kolchak, Nikolai A, et al.
Publicado: (2017)

Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro
por: Wang, Zijun, et al.
Publicado: (2020)

Development of IgA vasculitis after SARS‐CoV‐2 vaccination
por: Ogura, Yasuaki, et al.
Publicado: (2022)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Population-based seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city
por: Prakash, Om, et al.
Publicado: (2021)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Autoimmunity complicating SARS-CoV-2 infection in selective IgA-deficiency
por: Pfeuffer, Steffen, et al.
Publicado: (2020)

Anti-SARS-Cov-2 IgA Response in Tears of COVID-19 Patients
por: Caselli, Elisabetta, et al.
Publicado: (2020)

IgA dominates the early neutralizing antibody response to SARS-CoV-2
por: Sterlin, Delphine, et al.
Publicado: (2021)

IgA nephropathy with glomerular capillary IgA deposition following SARS-CoV-2 mRNA vaccination: a report of three cases
por: Yokote, Shinya, et al.
Publicado: (2022)

SARS-CoV-2 viral loads and serum IgA/IgG immune responses in critically ill COVID-19 patients
por: Fourati, Slim, et al.
Publicado: (2020)

Tripterygium Wilfordii inhibits tonsillar IgA production by downregulating IgA class switching in IgA nephropathy
por: Li, Huining, et al.
Publicado: (2017)

IgA Staining Patterns Differentiate Between IgA Nephropathy and IgA-Dominant Infection-Associated Glomerulonephritis
por: Brodsky, Sergey V., et al.
Publicado: (2020)

The real life performance of 7 automated anti-SARS-CoV-2 IgG and IgM/IgA immunoassays
por: Swadźba, Jakub, et al.
Publicado: (2021)

Increased Urinary IgA in Paediatric IgA Vasculitis Nephritis
por: Marro, Julien, et al.
Publicado: (2022)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies
por: Beavis, Kathleen G., et al.
Publicado: (2020)

Development and validation of an enzyme immunoassay for detection and quantification of SARS-CoV-2 salivary IgA and IgG
por: Costantini, Veronica P., et al.
Publicado: (2021)

Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients
por: Crescenzo-Chaigne, Bernadette, et al.
Publicado: (2021)

Long-term SARS-CoV-2 RNA Shedding and its Temporal Association to IgG Seropositivity
por: Agarwal, Vineet, et al.
Publicado: (2020)

Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity
por: Agarwal, Vineet, et al.
Publicado: (2020)

False positive Herpes Simplex IgM serology in COVID-19 patients correlates with SARS-CoV-2 IgM/IgG seropositivity
por: Vandervore, Laura, et al.
Publicado: (2022)

Development of SARS-CoV-2 specific IgG and IgA antibodies in serum and milk with different SARS-COV-2 vaccines in lactating women
por: Lechosa-Muñiz, Carolina, et al.
Publicado: (2023)

Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern
por: Santos da Silva, Eveline, et al.
Publicado: (2023)

Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories
por: Gkoliou, Glykeria, et al.
Publicado: (2023)

IgA-Dominant Infection-Associated Glomerulonephritis Following SARS-CoV-2 Infection
por: Pérez, Aurora, et al.
Publicado: (2021)

Gross hematuria following SARS-CoV-2 vaccination in patients with IgA nephropathy
por: Perrin, Peggy, et al.
Publicado: (2021)

Heterologous SARS‐CoV‐2 IgA neutralising antibody responses in convalescent plasma
por: Davis, Samantha K, et al.
Publicado: (2022)

The Functional Role of IgA in the IgM/IgA-Enriched Immunoglobulin Preparation Trimodulin
por: Bohländer, Fabian, et al.
Publicado: (2021)

Management of IgA Nephropathy in Pediatric Patients
por: Schroda, Sophie, et al.
Publicado: (2022)

SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on
por: Korte, Wolfgang, et al.
Publicado: (2021)

Is SARS-CoV-2 Neutralized More Effectively by IgM and IgA than IgG Having the Same Fab Region?
por: Pisil, Yalcin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6ck1vjmgdktjgl0q10fe5n0gnk